News

Investors Encouraged to Join Class Action Against Wildermuth Funds

Investors Encouraged to Join Class Action Against Wildermuth Funds

Class Action Lawsuit for Wildermuth Fund Investors

The law firm Bronstein, Gewirtz & Grossman, LLC, is reaching out to investors who have incurred significant losses while investing in the Wildermuth Fund. Their recent announcement highlights an active class action lawsuit aimed at holding the Fund's management accountable for alleged mismanagement and misrepresentation of critical information.

Details of the Class Action

This lawsuit seeks to represent all individuals and entities that purchased shares in the Wildermuth mutual fund during a specified period. The focus is on the Class A (WESFX), Class C (WEFCX), and Class I (WEIFX) shares from November 1, 2020, to June 29, 2023. The firm is encouraging affected investors to step forward and actively participate in the legal proceedings.

Understanding the Allegations

The complaint filed against the Wildermuth Fund alleges that the management made materially false and misleading statements about the Fund's operations and compliance policies, leading to significant investor losses. Some of the claims include an inaccurate valuation of the Fund's investments without adequate evidence and an alleged failure to disclose critical financial health indicators of portfolio companies.

Implications for Investors

Investors are assured that they have the right to claim damages if they were adversely affected during the class period. The class action aims to recover these losses, and victims are encouraged to gather evidence, document their experiences, and report them to their legal representatives.

Next Steps for Investors

If you are a Wildermuth Fund investor who believes they qualify as part of the class action, it is time to take action. The law firm suggests that investors reach out for a copy of the complaint and fully understand their rights and options moving forward. This process is intended to empower investors in highlighting their grievances against the firm's management.

No Costs Involved

It's crucial to understand that participating in this class action comes at no upfront cost to investors. The law firm operates on a contingency fee basis, meaning they will only recoup expenses and fees if the lawsuit is successful. Investors should feel reassured that their financial security won’t be compromised while seeking justice.

Why Choose Bronstein, Gewirtz & Grossman?

Bronstein, Gewirtz & Grossman is a reputable law firm known for its dedication to protecting investor rights through various securities fraud class actions. With a proven track record of recovering substantial settlements for their clients, they are well-equipped to navigate the complexities of such legal proceedings.

Get in Touch

For more information about the class action or to see if you qualify, contact Bronstein, Gewirtz & Grossman directly. You can reach Peretz Bronstein or Nathan Miller at 332-239-2660, or via email for any inquiries regarding your case. They are available to assist you in understanding the next steps and securing your position in the lawsuit.

Frequently Asked Questions

What is the class action lawsuit about?

The lawsuit focuses on recovery for investors who suffered losses in the Wildermuth Fund due to alleged mismanagement and misrepresentation of the Fund's financial health.

Who is eligible to join the lawsuit?

Individuals or entities that invested in the Wildermuth Fund classes (WESFX, WEFCX, WEIFX) during the specified class period are eligible.

Are there any costs to participate?

No, there are no upfront costs involved. The law firm works on a contingency fee basis.

How long do I have to join the lawsuit?

The deadline to request to be appointed as lead plaintiff is until December 29, 2025.

How can I contact the law firm?

You can contact Peretz Bronstein or Nathan Miller at 332-239-2660 or email them for inquiries regarding the case.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 1

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 6

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 5

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 4

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 3

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading

Top 5 Most Recently Viewed Articles

Construction Leaders Unite to Combat Worker Suicide Crisis

Updated Category News Views 53

Construction Leaders Unite to Combat Worker Suicide Crisis In a significant move to address the alarming rate of suicide among construction workers, leading CEOs from prominent firms including Bechtel, Fluor, and Turner Construction Company have launched a new CEO Advisory Council. This initiative aims to drive awareness and develop effective solutions for mental health...

Continue Reading
Jack DiFranco Joins Woodward Park Partners Amid Growth Surge

Updated Category News Views 432

New Face, New Opportunities Talk about a shake-up! Woodward Park Partners just snagged Jack DiFranco, a heavyweight in the mergers and acquisitions arena. This isn’t just a name drop; we’re talking about 35 years of serious industry grind under his belt. DiFranco isn't just here to fill a seat; he’s got the chops to elevate this firm into a new realm of...

Continue Reading
BitMine's Ethereum Strategy Surges with $2 Billion in Holdings

Updated Category News Views 267

BitMine's Revolutionary Ethereum Holdings Strategy BitMine Immersion Technologies has achieved a remarkable milestone by surpassing $2 billion in Ethereum (ETH) holdings. This significant increase over the initial $250 million capital raise demonstrates the company's strong asset management and commitment to its treasury strategy. The journey began with a private...

Continue Reading
Fennec Pharmaceuticals Prepares for Q1 2025 Results Announcement

Updated Category News Views 139

Fennec Pharmaceuticals Set to Release Quarterly Financial Results RESEARCH TRIANGLE PARK, N.C. -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a dedicated specialty pharmaceutical company, has made an important announcement regarding its first quarter financial results for 2025. The company is on track to unveil these results before the U.S. financial markets...

Continue Reading
Stellantis Faces Lowest Italian Vehicle Production in Decades

Updated Category News Views 376

Stellantis and Its Production Challenges in Italy Stellantis (NYSE: STLA), the result of a major merger between iconic brands, is experiencing a notable decline in vehicle production within Italy. This setback is particularly concerning as it represents the lowest output levels this country has seen since 1956. Declining Production Figures Reported Recent data from union...

Continue Reading